Group One Trading
ONC

Group One Trading’s BeOne Medicines Ltd ONC Stock Holding History

Group One Trading’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-200
Closed -$48.4K – 9320
2025
Q2 		$48.4K Buy
200
+100
+100% +$24.5K ﹤0.01% 5602
2025
Q1 		$27.2K Buy
+100
New +$23.4K ﹤0.01% 5606
2024
Q4 		– Sell
-2,400
Closed -$539K – 8094
2024
Q3 		$539K Hold
2,400
– – ﹤0.01% 2793
2024
Q2 		$342K Buy
+2,400
New +$370K ﹤0.01% 2912
2023
Q4 		– Sell
-300
Closed -$54K – 8335
2023
Q3 		$54K Sell
300
-200
-40% -$39.6K ﹤0.01% 5025
2023
Q2 		$89.2K Buy
500
+200
+67% +$46.1K ﹤0.01% 4733
2023
Q1 		$64.7K Buy
+300
New +$72K ﹤0.01% 4663
2022
Q4 		– Sell
-200
Closed -$27K – 8244
2022
Q3 		$27K Sell
200
-200
-50% -$34.3K ﹤0.01% 5890
2022
Q2 		$65K Sell
400
-100
-20% -$15.6K ﹤0.01% 5347
2022
Q1 		$94K Sell
500
-7,700
-94% -$1.64M ﹤0.01% 5553
2021
Q4 		$2.22M Buy
8,200
+8,100
+8,100% +$2.73M ﹤0.01% 2486
2021
Q3 		$36K Sell
100
-300
-75% -$98.1K ﹤0.01% 6801
2021
Q2 		$137K Sell
400
-5,200
-93% -$1.72M ﹤0.01% 5634
2021
Q1 		$1.95M Buy
5,600
+300
+6% +$99.3K ﹤0.01% 2490
2020
Q4 		$1.37M Buy
5,300
+3,200
+152% +$881K ﹤0.01% 2357
2020
Q3 		$602K Buy
2,100
+2,000
+2,000% +$470K ﹤0.01% 2682
2020
Q2 		$19K Sell
100
-2,400
-96% -$391K ﹤0.01% 4860
2020
Q1 		$308K Sell
2,500
-10,300
-80% -$1.61M ﹤0.01% 2409
2019
Q4 		$2.12M Sell
12,800
-30,000
-70% -$4.98M 0.01% 1244
2019
Q3 		$5.24M Buy
42,800
+40,800
+2,040% +$5.42M 0.04% 548
2019
Q2 		$248K Buy
+2,000
New +$254K ﹤0.01% 2695
2019
Q1 		– Sell
-5,000
Closed -$701K – 5468
2018
Q4 		$701K Sell
5,000
-2,500
-33% -$332K 0.01% 1768
2018
Q3 		$1.29M Buy
7,500
+5,400
+257% +$908K 0.01% 1489
2018
Q2 		$323K Sell
2,100
-500
-19% -$89.2K ﹤0.01% 2659
2018
Q1 		$437K Buy
+2,600
New +$352K ﹤0.01% 2163

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Group One Trading's ONC Position: Q1 2026 in Review

Group One Trading sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 200 shares — an estimated $60.8K sold.

Group One Trading first reported a position in ONC in Q2 2018 and held it in 16 quarters. The position peaked at $1.42M in Q4 2020. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Group One Trading reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 200 BeOne Medicines Ltd shares in Q1 2026, an estimated $60.8K.
  • Group One Trading first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 16 quarters.
  • Group One Trading's BeOne Medicines Ltd position peaked at $1.42M in Q4 2020.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.